Zentalis Pharmaceuticals Inc (NASDAQ:ZNTL)
| 42.22 Delayed Data As of 3:59pm ET |  -1.57 / -3.59%Today’s Change | 22.00 Today|||52-Week Range 61.29 | -18.71% Year-to-Date |
Latest ZNTL News | Press Releases
No recent news for Zentalis Pharmaceuticals Inc.
Today’s Trading
| Previous close | 43.79 |
| Today’s open | 44.37 |
| Day’s range | 41.96 - 44.37 |
| Volume | 6,197 |
| Average volume (3 months) | 313,937 |
| Market cap | $1.8B |
Data as of 3:59pm ET, 01/26/2021
Growth & Valuation
| Earnings growth (last year) | -116.74% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -100.00% |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | -- |
Competitors
| No competitors data available. |
Financials
| Next reporting date | May 14, 2021 |
| EPS forecast (this quarter) | -$1.03 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$45.7M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters --, -- |
Forecasts
